Trial Profile
Monitoring Tolerance, Safety and Acceptance of Depo-Eligard in an Open Label, Retrospective, Non-Interventional Clinical Trial.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Leuprorelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Astellas Pharma
- 23 Jan 2010 Actual patient number (140) added as reported by ClinicalTrials.gov.
- 23 Jan 2010 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 23 Jan 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.